Differential expression levels of SLC2A1 have been observed between ADC and SCC [32], and overexpression of SLC2A1 in stage I NSCLC resulted in poor survival in another experiment [33]. This evidence concerns the gene SLC2A1 and non-small cell lung carcinoma.